Arafath (Rafa) Najumudeen obtained his Ph.D. in 2016 under the supervision of Prof. Daniel Abankwa at Turku Bioscience working on mechanisms to target Ras protein clustering. In 2016, Rafa moved to CRUK Beatson Institute in the UK to pursue his postdoctoral studies, working on preclinical models of intestinal cancers in the lab led by Prof. Owen J. Sansom. His studies focused on defining role of metabolic rewiring in colorectal cancer initiation and progression using state-of-the-art preclinical cancer models. He recently returned to Finland, having been awarded the Academy of Finland Research Fellowship, and now heads an independent laboratory at the Institute of Biotechnology, HiLIFE, University of Helsinki.